cetylpyridinium chloride anhydrous has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogh, J; De Angelis, PM; Haraldsen, G; Küchler, AM; Manley, L; Pollheimer, J; Scott, H; Sorensen, DR; Sponheim, J | 1 |
| Blonski, JZ; Gora-Tybor, J; Jamroziak, K; Jesionek-Kupnicka, D; Krawczynska, A; Lech-Maranda, E; Robak, T; Szmigielska-Kaplon, A; Wierzbowska, A | 1 |
| Chatterjee, S; Ilayaraja, M; Majumder, S; Seerapu, HR; Siamwala, JH; Sinha, S | 1 |
| Autiero, M; Carmeliet, P; Chorianopoulos, E; Collen, D; De Mol, M; Dewerchin, M; Fischer, C; Giacca, M; Jonckx, B; Koch, M; Liesenborghs, L; Loges, S; Mazzone, M; Moons, L; Pattarini, L; Plaisance, S; Stassen, JM; van Rooijen, N; Wyns, S; Zacchigna, S | 1 |
4 other study(ies) available for cetylpyridinium chloride anhydrous and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.
Topics: Animals; Blood Vessels; Cell Count; Cell Movement; Cell Nucleus; Cells, Cultured; Cytokines; Down-Regulation; Endothelium; Female; Health; Humans; Inflammation; Interleukin-33; Interleukins; Neoplasms; Neovascularization, Pathologic; Rats; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2008 |
Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow; Cell Movement; Endothelial Cells; Female; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Prognosis | 2009 |
Chick embryo partial ischemia model: a new approach to study ischemia ex vivo.
Topics: Acetanilides; Animals; Apoptosis; Blood Vessels; Cell Proliferation; Cell Survival; Chick Embryo; Creatine Kinase, MB Form; Disease Models, Animal; Edema; Endothelial Cells; Glutathione; Goats; Health; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Myocardium; Neovascularization, Pathologic; Organ Specificity; Piperazines; Ranolazine; Reactive Oxygen Species; Time Factors; Vascular Surgical Procedures | 2010 |
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Blood Vessels; Cell Line; Cell Movement; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug-Related Side Effects and Adverse Reactions; Health; Humans; Lymphangiogenesis; Macrophages; Mice; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Placenta Growth Factor; Pregnancy Proteins; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2007 |